Moderna plans to invest up to $500 million to build a factory in Africa to make up to 500 million doses of mRNA vaccines each year, including its COVID-19 shot, as pressure grows on the pharmaceutical industry to manufacture drugs on the continent. As of early October, only about 4.5% of Africans had been fully vaccinated against COVID-19. Potential candidates to host Moderna’s African plant include South Africa, Rwanda and Senegal, health experts say, although a senior South African official involved in a drive to boost local vaccine manufacturing said he wasn’t aware of the Moderna announcement.
Source : Reuters
